Malassezia species in healthy skin and in dermatological conditions

International Journal of Dermatology

Volumn 55, Issue 5, 2016, Pages 494-504

  Prohic, Asja ^a   Jovovic Sadikovic, Tamara ^a   Krupalija Fazlic, Mersiha ^a   Kuskunovic Vlahovljak, Suada ^b  

^a KLINICKI CENTAR UNIVERZITETA U SARAJEVU   (Bosnia and Herzegovina)

^b UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; POSACONAZOLE; ANTIFUNGAL AGENT;

ANTIFUNGAL SUSCEPTIBILITY; ATOPIC DERMATITIS; BROTH DILUTION; COMMENSAL; FUNGAL EXAMINATION; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS CULTURE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; IN VITRO STUDY; MALASSEZIA; MALASSEZIA DERMATIS; MALASSEZIA DERMATITIS; MALASSEZIA FOLLICULITIS; MALASSEZIA FURFUR; MALASSEZIA GLOBOSA; MALASSEZIA JAPONICA; MALASSEZIA OBTUSA; MALASSEZIA PACHYDERMATIS; MALASSEZIA RESTRICTA; MALASSEZIA SLOOFFIAE; MALASSEZIA SYMPODIALIS; MALASSEZIA YAMATOENSIS; PSORIASIS; REVIEW; SEBORRHEIC DERMATITIS; SPECIES DISTRIBUTION; TINEA VERSICOLOR; DERMATOMYCOSIS; DRUG EFFECTS; FOLLICULITIS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; SKIN;

ANTIFUNGAL AGENTS; DERMATITIS, ATOPIC; DERMATITIS, SEBORRHEIC; DERMATOMYCOSES; FOLLICULITIS; HUMANS; MALASSEZIA; PSORIASIS; SKIN; TINEA VERSICOLOR;

EID: 84952684001     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/ijd.13116     Document Type: Review

References (101)

1. Ashbee HR. Update on the genus Malassezia. Med Mycol 2007; 45: 287-303.
2. Difonzo EM, Faggi E, Bassi A, et al. Malassezia skin diseases in humans. G Ital Dermatol Venereol 2013; 148: 609-619.
3. Crespo Erchiga V, Ojeda Martos AA, Vera Casaño A, et al. Isolation and identification of Malassezia spp. in pityriasis versicolor, seborrheic dermatitis and healthy skin. Rev Iberoam Micol 1999; 16: 16-21.
4. Heng MC, Henderson CL, Barker DC, et al. Correlation of Pityosporum ovale density with clinical severity of seborrheic dermatitis as assessed by a simplified technique. J Am Acad Dermatol 1990; 23: 82-86.
5. Gündüz K, Inanir I, Sacar H. Efficacy of terbinafine 1% cream on seborrhoeic dermatitis. J Dermatol 2005; 32: 22-25.
6. Tragiannidis A, Bisping G, Koehler G, et al. Mini review: Malassezia infections in immunocompromised patients. Mycoses 2010; 53: 187-195.
7. Guého E, Midgley G, Guillot J. The genus Malassezia with description of four new species. Antonie Van Leeuwenhoek 1996; 69: 337-355.
8. Sugita T, Takashima M, Shinoda T, et al. New yeast species, Malassezia dermatis, isolated from a patient with atopic dermatitis. J Clin Microbiol 2002; 40: 1363-1367.
9. Sugita T, Takashima M, Kodama M, et al. Description of a new species Malassezia japonica and its detection in patients with atopic dermatitis and healthy subjects. J Clin Microbiol 2003; 41: 4695-4699.
10. Sugita T, Tajima M, Takashima M, et al. A new yeast, Malassezia yamatoensis, isolated from a patient with seborrheic dermatitis, and its distribution in patients and healthy subjects. Microbiol Immunol 2004; 48: 579-583.
11. Hirai A, Kano R, Makimura K, et al. Malassezia nana sp. nov., a novel lipid-dependent yeast species isolated from animals. Int J Syst Evol Microbiol 2004; 54: 623-627.
12. Cabañes FJ, Theelen B, Castellá G, et al. Two new lipid-dependent Malassezia species from domestic animals. FEMS Yeast Res 2007; 7: 1064-1076.
13. Cabañes FJ, Vega S, Castellá G. Malassezia cuniculi sp. nov., a novel yeast species isolated from rabbit skin. Med Mycol 2011; 49: 40-48.
14. Jagielski T, Rup E, Ziółkowska A, et al. Distribution of Malassezia species on the skin of patients with atopic dermatitis, psoriasis, and healthy volunteers assessed by conventional and molecular identification methods. BMC Dermatol 2014; 14: 3.
15. Guillot J, Bond R. Malassezia pachydermatis: a review. Med Mycol 1999; 37: 295-306.
16. Ayhan M, Sancak B, Karaduman A, et al. Colonization of neonate skin by Malassezia species: relationship with neonatal cephalic pustulosis. J Am Acad Dermatol 2007; 57: 1012-1018.
17. Nagata R, Nagano H, Ogishima D, et al. Transmission of the major skin microbiota, Malassezia, from mother to neonate. Pediatr Int 2012; 54: 350-355.
18. Roberts SOB. Pityrosporum orbiculare: incidence and distribution on clinically normal skin. Br J Dermatol 1969; 81: 265-269.
19. Sandström Falk MH, Tengvall Linder M, Johansson C, et al. The prevalence of Malassezia yeasts in patients with atopic dermatitis, seborrhoeic dermatitis and healthy controls. Acta Derm Venereol 2005; 85: 17-23.
20. Gupta AK, Kohli Y, Summerbell RC, et al. Quantitative culture of Malassezia species from different body sites of individuals with and without dermatoses. Med Mycol 2001; 38: 243-351.
21. Sugita T, Suto H, Unno T, et al. Molecular analysis of Malassezia microflora on the skin of atopic dermatitis patients and healthy subjects. J Clin Microbiol 2001; 39: 3486-3490.
22. Lee YW, Yim SM, Lim SH, et al. Quantitative investigation on the distribution of Malassezia species on healthy human skin in Korea. Mycoses 2006; 49: 405-410.
23. Nakabayashi A, Sei Y, Guillot J. Identification of Malassezia species isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Med Mycol 2000; 38: 337-341.
24. Tarazooie B, Kordbacheh P, Zaini F, et al. Study of the distribution of Malassezia species in patients with pityriasis versicolor and healthy individuals in Tehran, Iran. BMC Dermatol 2004; 4: 5.
25. Ben Salah S, Makni F, Marrakchi S, et al. Identification of Malassezia species from Tunisian patients with pityriasis versicolor and normal subjects. Mycoses 2005; 48: 242-245.
26. Zomorodian K, Mirhendi H, Tarazooie B, et al. Distribution of Malassezia species in patients with psoriasis and healthy individuals in Tehran, Iran. J Cutan Pathol 2008; 35: 1027-1031.
27. Tajima M, Sugita T, Nishikawa A, et al. Molecular analysis of Malassezia microflora in seborrheic dermatitis patients: comparison with other diseases and healthy subjects. J Invest Dermatol 2008; 128: 345-351.
28. Oh BH, Song YC, Lee YW, et al. Comparison of nested PCR and RFLP for identification and classification of Malassezia yeasts from healthy human skin. Ann Dermatol 2009; 21: 352-357.
29. Kaur M, Narang T, Bala M, et al. Study of the distribution of Malassezia species in patients with pityriasis versicolor and healthy individuals in Tertiary Care Hospital, Punjab. Indian J Med Microbiol 2013; 31: 270-274.
30. Prohic A, Simic D, Jovovic Sadikovic T, et al. Distribution of Malassezia species on healthy human skin in Bosnia and Herzegovina: correlation with body part, age and gender. Iran J Microbiol 2014; 6: 253-262.
31. Gupta AK, Kohli Y. Prevalence of Malassezia species on various body sites in clinically healthy subjects representing different age groups. Med Mycol 2004; 42: 35-42.
32. Crespo Erchiga V, Ojeda Martos A, Vera Casano A, et al. Malassezia globosa as the causative agent of pityriasis versicolor. Br J Dermatol 2000; 143: 799-803.
33. Aspiroz C, Ara M, Varea M, et al. Isolation of M. globosa and M. sympodialis from patients with pityriasis versicolor in Spain. Mycopathologia 2001; 154: 11-17.
34. Dutta S, Bajaj AK, Basu S, et al. Pityriasis versicolor: socioeconomic and clinico-mycologic study in India. Int J Dermatol 2002; 41: 823-824.
35. Gaitanis G, Velegraki A, Alexopoulos EC, et al. Distribution of Malassezia species in pityriasis versicolor and seborrhoeic dermatitis in Greece. Typing of the major pityriasis versicolor isolate M. globosa. Br J Dermatol 2006; 154: 854-859.
36. Morishita N, Sei Y, Sugita T. Molecular analysis of Malassezia microflora from patients with pityriasis versicolor. Mycopathologia 2006; 161: 61-65.
37. Prohic A, Ozegovic L. Malassezia species isolated from lesional and non-lesional skin in patients with pityriasis versicolor. Mycoses 2007; 50: 58-63.
38. Trabelsi S, Oueslati J, Fekih N, et al. Identification of Malassezia species from Tunisian patients with pityriasis versicolor. Tunis Med 2010; 88: 85-87.
39. Shah A, Koticha A, Ubale M, et al. Identification and speciation of Malassezia in patients clinically suspected of having pityriasis versicolor. Indian J Dermatol 2013; 58: 239.
40. Romano C, Mancianti F, Nardoni S, et al. Identification of Malassezia species isolated from patients with extensive forms of pityriasis versicolor in Siena, Italy. Rev Iberoam Micol 2013; 30: 231-234.
41. Xie Z, Ran Y, Zhang H, et al. An analysis of the Malassezia species distribution in the skin of patients with pityriasis versicolor in Chengdu, China. ScientificWorldJournal 2014; 2014: 182596.
42. Rodoplu G, Saracli MA, Gümral R, et al. Distribution of Malassezia species in patients with pityriasis versicolor in Turkey. J Mycol Med 2014; 24: 117-123.
43. Gupta AK, Kohli Y, Faergemann J, et al. Epidemiology of Malassezia yeasts associated with pityriasis versicolor in Ontario, Canada. Med Mycol 2001; 39: 199-206.
44. Giusiano G, Sosa Mde L, Rojas F, et al. Prevalence of Malassezia species in pityriasis versicolor lesions in northeast Argentina. Rev Iberoam Micol 2010; 27: 71-74.
45. Petry V, Tanhausen F, Weiss L, et al. Identification of Malassezia yeast species isolated from patients with pityriasis versicolor. An Bras Dermatol 2011; 86: 803-806.
46. Krisanty RI, Bramono K, Made Wisnu I. Identification of Malassezia species from pityriasis versicolor in Indonesia and its relationship with clinical characteristics. Mycoses 2009; 52: 257-262.
47. Juntachai W, Oura T, Murayama SY, et al. The lipolytic enzymes activities of Malassezia species. Med Mycol 2009; 47: 477-484.
48. Rubenstein RM, Malerich SA. Malassezia (Pityrosporum) folliculitis. J Clin Aesthet Dermatol 2014; 7: 937-941.
49. Ayers K, Sweeney SM, Wiss K. Pityrosporum folliculitis: diagnosis and management in 6 female adolescents with acne vulgaris. Arch Pediatr Adolesc Med 2005; 159: 64-67.
50. Durdu M, Güran M, Ilkit M. Epidemiological characteristics of Malassezia folliculitis and use of the May-Grünwald-Giemsa stain to diagnose the infection. Diagn Microbiol Infect Dis 2013; 76: 450-457.
51. Akaza N, Akamatsu H, Sasaki Y, et al. Malassezia folliculitis is caused by cutaneous resident Malassezia species. Med Mycol 2009; 47: 618-624.
52. Anane S, Chtourou O, Bodemer C, et al. Malassezia folliculitis in an infant. Med Mycol Case Rep 2013; 2: 72-74.
53. Ko JH, Lee YW, Choe YB, et al. Epidemiologic study of Malassezia yeasts in patients with Malassezia folliculitis by 26S rDNA PCR-RFLP analysis. Ann Dermatol 2011; 23: 177-184.
54. Cuétara MS, Aguilar A, Martin L, et al. Erlotinib associated with rosacea-like folliculitis and Malassezia sympodialis. Br J Dermatol 2006; 155: 477-479.
55. Lee YW, Lee SY, Lee Y, et al. Evaluation of expression of lipases and phospholipases of Malassezia restricta in patients with seborrheic dermatitis. Ann Dermatol 2013; 25: 310-314.
56. Kesavan S, Holland KT, Ingham E. The effects of lipid extraction on the immunomodulatory activity of Malassezia species in vitro. Med Mycol 2000; 38: 239-247.
57. Thomas DS, Ingham E, Bojar RA, et al. In vitro modulation of human keratinocyte pro- and anti-inflammatory cytokine production by the capsule of Malassezia species. FEMS Immunol Med Microbiol 2008; 54: 203-214.
58. Arsic Arsenijevic VS, Milobratovic D, Barac AM, et al. A laboratory-based study on patients with Parkinson's disease and seborrheic dermatitis: the presence and density of Malassezia yeasts, their different species and enzymes production. BMC Dermatol 2014; 14: 5.
59. Prohic A. Distribution of Malassezia species in seborrhoeic dermatitis: correlation with patients' cellular immune status. Mycoses 2009; 53: 344-349.
60. Zisova LG. Malassezia species and seborrheic dermatitis. Folia Med (Plovdiv) 2009; 51: 23-33.
61. Bergbrant IM, Johansson S, Robbins D, et al. An immunological study in patients with seborrhoeic dermatitis. Clin Exp Dermatol 1991; 16: 331-338.
62. Lally A, Casabonne D, Newton R, et al. Seborrheic dermatitis among Oxford renal transplant recipients. J Eur Acad Dermatol Venereol 2010; 24: 561-564.
63. Lee YW, Byun HJ, Kim BJ, et al. Distribution of Malassezia species on the scalp in Korean seborrheic dermatitis patients. Ann Dermatol 2011; 23: 156-161.
64. Hedayati MT, Hajheydari Z, Hajjar F, et al. Identification of Malassezia species isolated from Iranian seborrhoeic dermatitis patients. Eur Rev Med Pharmacol Sci 2010; 14: 63-68.
65. Zarei-Mahmoudabadi A, Zarrin M, Mehdinezhad F. Seborrheic dermatitis due to Malassezia species in Ahvaz, Iran. Iran J Microbiol 2013; 5: 268-271.
66. Sosa Mde L, Rojas F, Mangiaterra M, et al. Prevalence of Malassezia species associated with seborrheic dermatitis lesions in patients in Argentina. Rev Iberoam Micol 2013; 30: 239-242.
67. Zhang H, Ran Y, Xie Z, et al. Identification of Malassezia species in patients with seborrheic dermatitis in China. Mycopathologia 2013; 175: 83-89.
68. Gemmer CM, DeAngelis YM, Theelen B, et al. Fast, noninvasive method for molecular detection and differentiation of Malassezia yeast species on human skin and application of the method to dandruff microbiology. J Clin Microbiol 2002; 40: 3350-3357.
69. Brodská P, Panzner P, Pizinger K, et al. IgE-mediated sensitization to Malassezia in atopic dermatitis: more common in male patients and in head and neck type. Dermatitis 2014; 25: 120-126.
70. Svejgaard E, Larsen PØ, Deleuran M, et al. Treatment of head and neck dermatitis comparing itraconazole 200 mg and 400 mg daily for 1 week with placebo. J Eur Acad Dermatol Venereol 2004; 18: 445-449.
71. Sonesson A, Bartosik J, Christiansen J, et al. Sensitization to skin-associated microorganisms in adult patients with atopic dermatitis is of importance for disease severity. Acta Derm Venereol 2013; 93: 340-345.
72. Yim SM, Kim JY, Ko JH, et al. Molecular analysis of Malassezia microflora on the skin of the patients with atopic dermatitis. Ann Dermatol 2010; 22: 41-47.
73. Pilgram GS, Vissers DC, van der Meulen H, et al. Aberrant lipid organization in stratum corneum of patients with atopic dermatitis and lamellar ichthyosis. J Invest Dermatol 2001; 117: 710-717.
74. Casagrande BF, Flückiger S, Linder MT, et al. Sensitization to the yeast Malassezia sympodialis is specific for extrinsic and intrinsic atopic eczema. J Invest Dermatol 2006; 126: 2414-2421.
75. Kaga M, Sugita T, Nishikawa A, et al. Molecular analysis of the cutaneous Malassezia microbiota from the skin of patients with atopic dermatitis of different severities. Mycoses 2011; 54: 24-28.
76. Nestle FO, Kaplan DH, Barker J. Mechanisms of disease: psoriasis. N Engl J Med 2009; 361: 444-509.
77. Fry L, Baker BS, Powles AV, et al. Is chronic plaque psoriasis triggered by microbiota in the skin? Br J Dermatol 2013; 169: 47-52.
78. Faergemann J, Diehl U, Bergfelt L, et al. Scalp psoriasis: synergy between the Malassezia yeasts and skin irritation due to calcipotriol. Acta Derm Venereol 2003; 83: 438-441.
79. Rudramurthy SM, Honnavar P, Chakrabarti A, et al. Association of Malassezia species with psoriatic lesions. Mycoses 2014; 57: 483-488.
80. Kanda N, Tani K, Enomoto U, et al. The skin fungus-induced Th1- and Th2-related cytokine, chemokine and prostaglandin E2 production in peripheral blood mononuclear cells from patients with atopic dermatitis and psoriasis vulgaris. Clin Exp Allergy 2002; 32: 1243-1250.
81. Baroni A, Paoletti I, Ruocco E, et al. Possible role of Malassezia furfur in psoriasis: modulation of TGF-β1, integrin, and HSP70 expression in human keratinocytes and in the skin of psoriasis-affected patients. J Cutan Pathol 2004; 31: 35-42.
82. Farr PM, Krause LB, Marks JM, et al. Response of scalp psoriasis to oral ketoconazole. Lancet 1985; 26: 921-922.
83. Rosenberg EW, Belew PW. Improvement of psoriasis of the scalp with ketoconazole. Arch Dermatol 1982; 118: 370-371.
84. Prohic A. Identification of Malassezia species isolated from scalp skin of patients with psoriasis and healthy subjects. Acta Dermatovenerol Croat 2003; 11: 10-16.
85. Gomez-Moyano E, Crespo-Erchiga V, Martínez-Pilar L, et al. Do Malassezia species play a role in exacerbation of scalp psoriasis? J Mycol Med 2014; 24: 87-92.
86. Hernández Hernández F, Méndez Tovar LJ, Bazán Mora E, et al. Species of Malassezia associated with various dermatoses and healthy skin in the Mexican population. Rev Iberoam Micol 2003; 20: 141-144.
87. Amaya M, Tajima M, Okubo Y, et al. Molecular analysis of Malassezia microflora in the lesional skin of psoriasis patients. J Dermatol 2007; 34: 619-624.
88. Takahata Y, Sugita T, Hiruma M, et al. Quantitative analysis of Malassezia in the scale of patients with psoriasis using a real-time polymerase chain reaction assay. Br J Dermatol 2007; 157: 670-673.
89. Chowdhary A, Randhawa HS, Sharma S, et al. Malassezia furfur in a case of onychomycosis: colonizer or etiologic agent? Med Mycol 2005; 43: 87-90.
90. Silva V, Moreno GA, Zaror L, et al. Isolation of Malassezia furfur from patients with onychomycosis. J Med Vet Mycol 1997; 35: 73-74.
91. Tamraz H, Raffoul M, Kurban M, et al. Confluent and reticulated papillomatosis: clinical and histopathological study of 10 cases from Lebanon. J Eur Acad Dermatol Venereol 2013; 27: 119-123.
92. Numata S, Akamatsu H, Akaza N, et al. Analysis of facial skin-resident microbiota in Japanese acne patients. Dermatology 2014; 228: 86-92.
93. Cafarchia C, Gasser RB, Figueredo LA, et al. Advances in the identification of Malassezia. Mol Cell Probes 2011; 25: 1-7.
94. Lecerf P, Hay R. A new approach to the diagnosis and study of Malassezia infections. Br J Dermatol 2014; 170: 234.
95. Gupta AK, Kohli Y, Li A, et al. In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine. Br J Dermatol 2000; 142: 758-765.
96. Rojas FD, Sosa Mde L, Fernández MS, et al. Antifungal susceptibility of Malassezia furfur, Malassezia sympodialis, and Malassezia globosa to azole drugs and amphotericin B evaluated using a broth microdilution method. Med Mycol 2014; 52: 641-646.
97. Hammer KA, Carson CF, Riley TV. In vitro activities of ketoconazole, econazole, miconazole, and Melaleuca alternifolia (tea tree) oil against Malassezia species. Antimicrob Agents Chemother 2000; 44: 467-469.
98. Murai T, Nakamura Y, Kano R, et al. Susceptibility testing of Malassezia pachydermatis using the urea broth microdilution method. Mycoses 2002; 45: 84-87.
99. Garau M, Pereiro M Jr, del Palacio A. In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds. Antimicrob Agents Chemother 2003; 47: 2342-2344.
100. Velegraki A, Alexopoulos EC, Kritikou S, et al. Use of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to the new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27-A2 microdilution method and Etest. J Clin Microbiol 2004; 42: 3589-3593.
101. Cafarchia C, Figueredo LA, Iatta R, et al. In vitro evaluation of Malassezia pachydermatis susceptibility to azole compounds using E-test and CLSI microdilution methods. Med Mycol 2012; 50: 795-801.